ZOMETA^® effectively inhibits the vicious cycle of bone destruction in patients like Marta when given 4 mg every 3 to 4 weeks^10,12

Bone resorption marker decreases rapidly following administration of ZOMETA on day 1¹²
The effect of ZOMETA on bone resorption marker lessens after 3 to 4 weeks¹²

Change from baseline in bone resorption marker^*
(after single 4-mg dose of ZOMETA; N=12)¹²

*Urinary N-telopeptide/creatinine ratio was chosen as the surrogate marker.

Only dosing every 3 to 4 weeks has been proven effective in reducing
or delaying SREs^4,7,13,14

Page

1 2 3 4

Disclaimer: This is an international website for ZOMETA^® (zoledronic acid) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.

ZOMETA® effectively inhibits the vicious cycle of bone destruction in patients like Marta when given 4 mg every 3 to 4 weeks10,12

Only dosing every 3 to 4 weeks has been proven effective in reducingor delaying SREs4,7,13,14

ZOMETA^® effectively inhibits the vicious cycle of bone destruction in patients like Marta when given 4 mg every 3 to 4 weeks^10,12

Only dosing every 3 to 4 weeks has been proven effective in reducing
or delaying SREs^4,7,13,14